![logo-okklo](https://cdn.speedsize.com/3da3c958-185c-4218-abc7-2b54e37efcf5/https://test.kadans.com/wp-content/uploads/2018/09/logo-okklo.jpg)
Okklo Life Sciences
Okklo Life Sciences is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies, with a focus on neglected and orphan diseases.
The company was founded in December 2011 by a team of life-sciences experts previously involved in the development and approval of sugammadex (Bridion™), the first modified cyclodextrin (CD) marketed as a drug product.
Voor meer informatie klik hier.